Authors
Latest:
Influenza Triggers Immune Responses Resulting in Relapse in Patients with Multiple SclerosisA recent study investigates what causes relapse in those with multiple sclerosis and sought to glean insight into the brain activity of patients with MS during respiratory infections.
Latest:
Controversies in C Difficile PreventionNicola Petrosillo, MD, discusses current controversies in C difficile prevention and treatment.
Latest:
The Search for HIV-Associated Neurocognitive Disorder BiomarkersA recent commentary discusses the need to uncover diagnostic and prognostic biomarkers for HIV-associated neurocognitive disorder (HAND).
Latest:
What is on the Horizon for HIV Prevention?A new review in The Lancet HIV discusses the next generation of HIV prevention, called PrEP 2.0.
Latest:
A Look Into the Antimicrobial Stewardship Collaborative of South CarolinaProviders in other states can learn from this multiorganization collaborative that aims to improve antimicrobial utilization and prevent the emergence of antimicrobial resistance across South Carolina.
Latest:
Maintaining Patient Safety During a Water Intrusion in the ORHealth workers had to act quickly when 30,000 gallons of water spilled into the operating room of a level 1 trauma center in Texas.
Latest:
An Update on LenacapavirThis new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.
Latest:
Researchers Find Drug Combo Works Against Multidrug-Resistant BacteriaRecent research has found that a surprising drug combo might be the key to fighting multidrug-resistant bacteria.
Latest:
Risk for Cancer-Causing Infections Highest in Low- and Middle-Income CountriesDespite the progress that has been made, more research is needed on cancer prevention, hepatitis B, and human papillomavirus vaccines.
Latest:
RSV Roundtable: Disease Education, Vaccine Hesitancy, and AwarenessIn the second installment of the RSV Roundtable, our panel explains how they are educating patients and parents when it comes to RSV, vaccines and preventive measures, and limited treatment availability.
Latest:
Can Infectious Disease Physicians Help Prevent Violence?About 1.6 million individuals die from violence each year on a global scale—do infectious disease physicians have a role in preventing it?
Latest:
A "Bottom Up" Treatment for Ebola That Could Have Been Used in West AfricaAs sporadic cases of Ebola continue to arise in West Africa, a controversial approach could be utilized to increase survival rates in those who are infected.
Latest:
Treating Outpatient Cystitis in the Era of Antimicrobial ResistanceWhat can clinicians do now that increasing resistance has limited oral treatment options for outpatient cystitis?
Latest:
Examining Real-World Evidence for Oritavancin Use in Gram-Positive InfectionsThe challenges of making formulary and clinical decisions based on regulatory studies are significant and the need for real-world clinical experience is increasingly important.
Latest:
Treating Hepatitis C Virus and HIV Coinfections in Intravenous Drug UsersUnique considerations are called for when caring for intravenous drug users with newly diagnosed HIV/HCV coinfections.
Latest:
The Time for Antifungal Stewardship Programs Is NowThe growing threat of resistance and substantial costs for treating these infections accentuates the need for programs focused on appropriate treatment.
Latest:
Changes in Recommendations for Diagnosis, Disease Severity, and Treatment of C difficile Infection in the 2017 Update to the IDSA/SHEA Clinical Practice GuidelinesThe updated guidelines recommend targeting those with active infection and avoiding treatment of “carriers” of C difficile who are colonized but not symptomatic.
Latest:
An Unexpected Meningitis CulpritA team of physicians yields surprising findings in an elderly patient in shock with seizures.
Latest:
The Importance of Maintaining Antibiotic BreakpointsLaboratories that use revised carbapenem breakpoints detect significantly more carbapenem-resistant Enterobacteriaceae than laboratories that use historical ones.
Latest:
Benefits of Azithromycin Outweigh Risks in Elderly Hospitalized with PneumoniaAmong patients aged 65 years or older who are hospitalized with community-acquired pneumonia, azithromycin lowers the risk of 90-day mortality in exchange for slightly increased odds of myocardial infarction compared to other antibiotic regimens.
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
About Half of Millennials Are Not Getting Tested For HIVA recent CDC report finds those between 15 and 44 years of age are significantly more likely to have never been tested for HIV.
Latest:
Accurate Data Is Key in Raising Hand Hygiene Compliance and Improving Patient SafetyThe Joint Commission considers hand hygiene the most important intervention for preventing healthcare-associated infections, which are responsible for 75,000 deaths annually.
Latest:
Addressing Weight Gain That Follows Life-Saving Antiretroviral TherapyClinicians must identify when additional pounds cross the line of diminishing return.
Latest:
Taking Action to Address Critical Gaps in Teen ImmunizationAccording to recent data from the Centers for Disease Control and Prevention, millions of Americans aged 13-17 are under-vaccinated against serious infectious diseases.
Latest:
The State of PrEP in 2017: Recent Data and Current ChallengesAlthough a once-daily pill to prevent HIV exists, US populations at highest risk have the lowest rates of usage.
Latest:
Investigational Treatments for Clostridioides difficile InfectionThe high recurrence rates of Clostridioides difficile infection highlight the need for novel agents with unique mechanisms of action for treating the infection.
